Cargando…
COSUMO: study protocol for the development of a core outcome set for efficacy and effectiveness trials in posterior segment-involving uveitis
BACKGROUND: Uveitis, a group of disorders characterised by intraocular inflammation, causes 10–15% of total blindness in the developed world. The most sight-threatening uveitis affects the posterior segment of the eye (posterior-segment involving uveitis (PSIU)). Numerous different outcomes have bee...
Autores principales: | Tallouzi, Mohammad O., Mathers, Jonathan M., Moore, David J., Murray, Philip I., Bucknall, Nicholas, Blazeby, Jane M., Calvert, Melanie, Denniston, Alastair K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709828/ https://www.ncbi.nlm.nih.gov/pubmed/29191216 http://dx.doi.org/10.1186/s13063-017-2294-8 |
Ejemplares similares
-
Outcomes important to patients with non-infectious posterior segment-involving uveitis: a qualitative study
por: Tallouzi, Mohammad O, et al.
Publicado: (2020) -
Healthcare professionals’ views on the most important outcomes for non-infectious uveitis of the posterior segment: A qualitative study
por: Tallouzi, Mohammad O., et al.
Publicado: (2023) -
The effectiveness of pharmacological agents for the treatment of uveitic macular oedema (UMO): a systematic review protocol
por: Tallouzi, Mohammad O., et al.
Publicado: (2016) -
mTOR-inhibiting pharmacotherapy for the treatment of non-infectious uveitis: a systematic review protocol
por: Blair, Joshua, et al.
Publicado: (2018) -
Instrument-based tests for measuring anterior chamber cells in uveitis: a systematic review protocol
por: Liu, Xiaoxuan, et al.
Publicado: (2019)